1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-invasive Preimplantation Genetic Testing Market Research Report 2023
Published Date: November 2023
|
Report Code: QYRE-Auto-5R15711
Home | Market Reports | Health| Reproductive Health
Global Non invasive Preimplantation Genetic Testing Market Research Report 2023
BUY CHAPTERS

Global Non-invasive Preimplantation Genetic Testing Market Research Report 2023

Code: QYRE-Auto-5R15711
Report
November 2023
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-invasive Preimplantation Genetic Testing Market

Non-invasive preimplantation genetic testing (NI-PGT) is a technique used in assisted reproductive technology (ART) to assess the genetic makeup of embryos before they are implanted into the uterus during in vitro fertilization (IVF).
According to new survey, global Non-invasive Preimplantation Genetic Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
Key manufacturers engaged in the Non-invasive Preimplantation Genetic Testing industry include Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, Abbott, TAKARA, QIAGEN and Vitrolife, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Non-invasive Preimplantation Genetic Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-invasive Preimplantation Genetic Testing market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-invasive Preimplantation Genetic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Non-invasive Preimplantation Genetic Testing Market Report

Report Metric Details
Report Name Non-invasive Preimplantation Genetic Testing Market
Segment by Type
  • Preimplantation Genetic Screening
  • Preimplantation Genetic Diagnosis
Segment by Application
  • Hospitals
  • Diagnostic Laboratories
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, Abbott, TAKARA, QIAGEN, Vitrolife, Oxford Nanopore Technologies, Yikon Genomics, Shiva Scientific, Medicover Genetics, MedGenome, Fulgent, INVICTA GENETICS, Genea Fertility, Bioarray, GeneMind Biosciences, Unimed Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

Who are the main players in the Non-invasive Preimplantation Genetic Testing Market report?

Ans: The main players in the Non-invasive Preimplantation Genetic Testing Market are Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, Abbott, TAKARA, QIAGEN, Vitrolife, Oxford Nanopore Technologies, Yikon Genomics, Shiva Scientific, Medicover Genetics, MedGenome, Fulgent, INVICTA GENETICS, Genea Fertility, Bioarray, GeneMind Biosciences, Unimed Biotech

What are the Application segmentation covered in the Non-invasive Preimplantation Genetic Testing Market report?

Ans: The Applications covered in the Non-invasive Preimplantation Genetic Testing Market report are Hospitals, Diagnostic Laboratories, Other

What are the Type segmentation covered in the Non-invasive Preimplantation Genetic Testing Market report?

Ans: The Types covered in the Non-invasive Preimplantation Genetic Testing Market report are Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis

1 Non-invasive Preimplantation Genetic Testing Market Overview
1.1 Product Overview and Scope of Non-invasive Preimplantation Genetic Testing
1.2 Non-invasive Preimplantation Genetic Testing Segment by Type
1.2.1 Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Type (2023-2029)
1.2.2 Preimplantation Genetic Screening
1.2.3 Preimplantation Genetic Diagnosis
1.3 Non-invasive Preimplantation Genetic Testing Segment by Application
1.3.1 Global Non-invasive Preimplantation Genetic Testing Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Other
1.4 Global Non-invasive Preimplantation Genetic Testing Market Size Estimates and Forecasts
1.4.1 Global Non-invasive Preimplantation Genetic Testing Revenue 2018-2029
1.4.2 Global Non-invasive Preimplantation Genetic Testing Sales 2018-2029
1.4.3 Global Non-invasive Preimplantation Genetic Testing Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non-invasive Preimplantation Genetic Testing Market Competition by Manufacturers
2.1 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-invasive Preimplantation Genetic Testing Average Price by Manufacturers (2018-2023)
2.4 Global Non-invasive Preimplantation Genetic Testing Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Product Type & Application
2.7 Non-invasive Preimplantation Genetic Testing Market Competitive Situation and Trends
2.7.1 Non-invasive Preimplantation Genetic Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-invasive Preimplantation Genetic Testing Players Market Share by Revenue
2.7.3 Global Non-invasive Preimplantation Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-invasive Preimplantation Genetic Testing Retrospective Market Scenario by Region
3.1 Global Non-invasive Preimplantation Genetic Testing Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-invasive Preimplantation Genetic Testing Global Non-invasive Preimplantation Genetic Testing Sales by Region: 2018-2029
3.2.1 Global Non-invasive Preimplantation Genetic Testing Sales by Region: 2018-2023
3.2.2 Global Non-invasive Preimplantation Genetic Testing Sales by Region: 2024-2029
3.3 Global Non-invasive Preimplantation Genetic Testing Global Non-invasive Preimplantation Genetic Testing Revenue by Region: 2018-2029
3.3.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Region: 2018-2023
3.3.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Region: 2024-2029
3.4 North America Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country
3.4.1 North America Non-invasive Preimplantation Genetic Testing Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2029)
3.4.3 North America Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country
3.5.1 Europe Non-invasive Preimplantation Genetic Testing Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2029)
3.5.3 Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country
3.6.1 Asia Pacific Non-invasive Preimplantation Genetic Testing Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country
3.7.1 Latin America Non-invasive Preimplantation Genetic Testing Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2029)
3.7.3 Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-invasive Preimplantation Genetic Testing Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2029)
4.1.1 Global Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023)
4.1.2 Global Non-invasive Preimplantation Genetic Testing Sales by Type (2024-2029)
4.1.3 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2029)
4.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2018-2029)
4.2.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2018-2023)
4.2.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2024-2029)
4.2.3 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2018-2029)
4.3 Global Non-invasive Preimplantation Genetic Testing Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2029)
5.1.1 Global Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023)
5.1.2 Global Non-invasive Preimplantation Genetic Testing Sales by Application (2024-2029)
5.1.3 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2029)
5.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2018-2029)
5.2.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2018-2023)
5.2.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2024-2029)
5.2.3 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2018-2029)
5.3 Global Non-invasive Preimplantation Genetic Testing Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Illumina
6.1.1 Illumina Corporation Information
6.1.2 Illumina Description and Business Overview
6.1.3 Illumina Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Illumina Non-invasive Preimplantation Genetic Testing Product Portfolio
6.1.5 Illumina Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Corporation Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Agilent
6.3.1 Agilent Corporation Information
6.3.2 Agilent Description and Business Overview
6.3.3 Agilent Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Agilent Non-invasive Preimplantation Genetic Testing Product Portfolio
6.3.5 Agilent Recent Developments/Updates
6.4 Revvity
6.4.1 Revvity Corporation Information
6.4.2 Revvity Description and Business Overview
6.4.3 Revvity Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Revvity Non-invasive Preimplantation Genetic Testing Product Portfolio
6.4.5 Revvity Recent Developments/Updates
6.5 The Cooper Companies
6.5.1 The Cooper Companies Corporation Information
6.5.2 The Cooper Companies Description and Business Overview
6.5.3 The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.5.4 The Cooper Companies Non-invasive Preimplantation Genetic Testing Product Portfolio
6.5.5 The Cooper Companies Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Abbott Non-invasive Preimplantation Genetic Testing Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 TAKARA
6.6.1 TAKARA Corporation Information
6.6.2 TAKARA Description and Business Overview
6.6.3 TAKARA Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.4.4 TAKARA Non-invasive Preimplantation Genetic Testing Product Portfolio
6.7.5 TAKARA Recent Developments/Updates
6.8 QIAGEN
6.8.1 QIAGEN Corporation Information
6.8.2 QIAGEN Description and Business Overview
6.8.3 QIAGEN Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.8.4 QIAGEN Non-invasive Preimplantation Genetic Testing Product Portfolio
6.8.5 QIAGEN Recent Developments/Updates
6.9 Vitrolife
6.9.1 Vitrolife Corporation Information
6.9.2 Vitrolife Description and Business Overview
6.9.3 Vitrolife Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Vitrolife Non-invasive Preimplantation Genetic Testing Product Portfolio
6.9.5 Vitrolife Recent Developments/Updates
6.10 Oxford Nanopore Technologies
6.10.1 Oxford Nanopore Technologies Corporation Information
6.10.2 Oxford Nanopore Technologies Description and Business Overview
6.10.3 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product Portfolio
6.10.5 Oxford Nanopore Technologies Recent Developments/Updates
6.11 Yikon Genomics
6.11.1 Yikon Genomics Corporation Information
6.11.2 Yikon Genomics Non-invasive Preimplantation Genetic Testing Description and Business Overview
6.11.3 Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Yikon Genomics Non-invasive Preimplantation Genetic Testing Product Portfolio
6.11.5 Yikon Genomics Recent Developments/Updates
6.12 Shiva Scientific
6.12.1 Shiva Scientific Corporation Information
6.12.2 Shiva Scientific Non-invasive Preimplantation Genetic Testing Description and Business Overview
6.12.3 Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Shiva Scientific Non-invasive Preimplantation Genetic Testing Product Portfolio
6.12.5 Shiva Scientific Recent Developments/Updates
6.13 Medicover Genetics
6.13.1 Medicover Genetics Corporation Information
6.13.2 Medicover Genetics Non-invasive Preimplantation Genetic Testing Description and Business Overview
6.13.3 Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Medicover Genetics Non-invasive Preimplantation Genetic Testing Product Portfolio
6.13.5 Medicover Genetics Recent Developments/Updates
6.14 MedGenome
6.14.1 MedGenome Corporation Information
6.14.2 MedGenome Non-invasive Preimplantation Genetic Testing Description and Business Overview
6.14.3 MedGenome Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.14.4 MedGenome Non-invasive Preimplantation Genetic Testing Product Portfolio
6.14.5 MedGenome Recent Developments/Updates
6.15 Fulgent
6.15.1 Fulgent Corporation Information
6.15.2 Fulgent Non-invasive Preimplantation Genetic Testing Description and Business Overview
6.15.3 Fulgent Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Fulgent Non-invasive Preimplantation Genetic Testing Product Portfolio
6.15.5 Fulgent Recent Developments/Updates
6.16 INVICTA GENETICS
6.16.1 INVICTA GENETICS Corporation Information
6.16.2 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Description and Business Overview
6.16.3 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.16.4 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product Portfolio
6.16.5 INVICTA GENETICS Recent Developments/Updates
6.17 Genea Fertility
6.17.1 Genea Fertility Corporation Information
6.17.2 Genea Fertility Non-invasive Preimplantation Genetic Testing Description and Business Overview
6.17.3 Genea Fertility Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Genea Fertility Non-invasive Preimplantation Genetic Testing Product Portfolio
6.17.5 Genea Fertility Recent Developments/Updates
6.18 Bioarray
6.18.1 Bioarray Corporation Information
6.18.2 Bioarray Non-invasive Preimplantation Genetic Testing Description and Business Overview
6.18.3 Bioarray Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Bioarray Non-invasive Preimplantation Genetic Testing Product Portfolio
6.18.5 Bioarray Recent Developments/Updates
6.19 GeneMind Biosciences
6.19.1 GeneMind Biosciences Corporation Information
6.19.2 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Description and Business Overview
6.19.3 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.19.4 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product Portfolio
6.19.5 GeneMind Biosciences Recent Developments/Updates
6.20 Unimed Biotech
6.20.1 Unimed Biotech Corporation Information
6.20.2 Unimed Biotech Non-invasive Preimplantation Genetic Testing Description and Business Overview
6.20.3 Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Unimed Biotech Non-invasive Preimplantation Genetic Testing Product Portfolio
6.20.5 Unimed Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-invasive Preimplantation Genetic Testing Industry Chain Analysis
7.2 Non-invasive Preimplantation Genetic Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-invasive Preimplantation Genetic Testing Production Mode & Process
7.4 Non-invasive Preimplantation Genetic Testing Sales and Marketing
7.4.1 Non-invasive Preimplantation Genetic Testing Sales Channels
7.4.2 Non-invasive Preimplantation Genetic Testing Distributors
7.5 Non-invasive Preimplantation Genetic Testing Customers
8 Non-invasive Preimplantation Genetic Testing Market Dynamics
8.1 Non-invasive Preimplantation Genetic Testing Industry Trends
8.2 Non-invasive Preimplantation Genetic Testing Market Drivers
8.3 Non-invasive Preimplantation Genetic Testing Market Challenges
8.4 Non-invasive Preimplantation Genetic Testing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Non-invasive Preimplantation Genetic Testing Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Non-invasive Preimplantation Genetic Testing Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Non-invasive Preimplantation Genetic Testing Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Non-invasive Preimplantation Genetic Testing, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Product Type & Application
    Table 12. Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Non-invasive Preimplantation Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Preimplantation Genetic Testing as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Non-invasive Preimplantation Genetic Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Non-invasive Preimplantation Genetic Testing Sales by Region (2018-2023) & (K Units)
    Table 18. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2018-2023)
    Table 19. Global Non-invasive Preimplantation Genetic Testing Sales by Region (2024-2029) & (K Units)
    Table 20. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2024-2029)
    Table 21. Global Non-invasive Preimplantation Genetic Testing Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2018-2023)
    Table 23. Global Non-invasive Preimplantation Genetic Testing Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2024-2029)
    Table 25. North America Non-invasive Preimplantation Genetic Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023) & (K Units)
    Table 27. North America Non-invasive Preimplantation Genetic Testing Sales by Country (2024-2029) & (K Units)
    Table 28. North America Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Non-invasive Preimplantation Genetic Testing Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Non-invasive Preimplantation Genetic Testing Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Non-invasive Preimplantation Genetic Testing Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Non-invasive Preimplantation Genetic Testing Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Type (2018-2023)
    Table 51. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Type (2024-2029)
    Table 52. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
    Table 53. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2024-2029)
    Table 54. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2018-2023)
    Table 57. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2024-2029)
    Table 58. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Application (2018-2023)
    Table 61. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Application (2024-2029)
    Table 62. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
    Table 63. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2024-2029)
    Table 64. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2018-2023)
    Table 67. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2024-2029)
    Table 68. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Application (2024-2029)
    Table 70. Illumina Corporation Information
    Table 71. Illumina Description and Business Overview
    Table 72. Illumina Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. Illumina Non-invasive Preimplantation Genetic Testing Product
    Table 74. Illumina Recent Developments/Updates
    Table 75. Thermo Fisher Scientific Corporation Information
    Table 76. Thermo Fisher Scientific Description and Business Overview
    Table 77. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product
    Table 79. Thermo Fisher Scientific Recent Developments/Updates
    Table 80. Agilent Corporation Information
    Table 81. Agilent Description and Business Overview
    Table 82. Agilent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Agilent Non-invasive Preimplantation Genetic Testing Product
    Table 84. Agilent Recent Developments/Updates
    Table 85. Revvity Corporation Information
    Table 86. Revvity Description and Business Overview
    Table 87. Revvity Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. Revvity Non-invasive Preimplantation Genetic Testing Product
    Table 89. Revvity Recent Developments/Updates
    Table 90. The Cooper Companies Corporation Information
    Table 91. The Cooper Companies Description and Business Overview
    Table 92. The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. The Cooper Companies Non-invasive Preimplantation Genetic Testing Product
    Table 94. The Cooper Companies Recent Developments/Updates
    Table 95. Abbott Corporation Information
    Table 96. Abbott Description and Business Overview
    Table 97. Abbott Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. Abbott Non-invasive Preimplantation Genetic Testing Product
    Table 99. Abbott Recent Developments/Updates
    Table 100. TAKARA Corporation Information
    Table 101. TAKARA Description and Business Overview
    Table 102. TAKARA Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. TAKARA Non-invasive Preimplantation Genetic Testing Product
    Table 104. TAKARA Recent Developments/Updates
    Table 105. QIAGEN Corporation Information
    Table 106. QIAGEN Description and Business Overview
    Table 107. QIAGEN Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. QIAGEN Non-invasive Preimplantation Genetic Testing Product
    Table 109. QIAGEN Recent Developments/Updates
    Table 110. Vitrolife Corporation Information
    Table 111. Vitrolife Description and Business Overview
    Table 112. Vitrolife Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. Vitrolife Non-invasive Preimplantation Genetic Testing Product
    Table 114. Vitrolife Recent Developments/Updates
    Table 115. Oxford Nanopore Technologies Corporation Information
    Table 116. Oxford Nanopore Technologies Description and Business Overview
    Table 117. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product
    Table 119. Oxford Nanopore Technologies Recent Developments/Updates
    Table 120. Yikon Genomics Corporation Information
    Table 121. Yikon Genomics Description and Business Overview
    Table 122. Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 123. Yikon Genomics Non-invasive Preimplantation Genetic Testing Product
    Table 124. Yikon Genomics Recent Developments/Updates
    Table 125. Shiva Scientific Corporation Information
    Table 126. Shiva Scientific Description and Business Overview
    Table 127. Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 128. Shiva Scientific Non-invasive Preimplantation Genetic Testing Product
    Table 129. Shiva Scientific Recent Developments/Updates
    Table 130. Medicover Genetics Corporation Information
    Table 131. Medicover Genetics Description and Business Overview
    Table 132. Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 133. Medicover Genetics Non-invasive Preimplantation Genetic Testing Product
    Table 134. Medicover Genetics Recent Developments/Updates
    Table 135. MedGenome Corporation Information
    Table 136. MedGenome Description and Business Overview
    Table 137. MedGenome Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 138. MedGenome Non-invasive Preimplantation Genetic Testing Product
    Table 139. MedGenome Recent Developments/Updates
    Table 140. Fulgent Corporation Information
    Table 141. Fulgent Description and Business Overview
    Table 142. Fulgent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 143. Fulgent Non-invasive Preimplantation Genetic Testing Product
    Table 144. Fulgent Recent Developments/Updates
    Table 145. INVICTA GENETICS Corporation Information
    Table 146. INVICTA GENETICS Description and Business Overview
    Table 147. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 148. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product
    Table 149. INVICTA GENETICS Recent Developments/Updates
    Table 150. Genea Fertility Corporation Information
    Table 151. Genea Fertility Description and Business Overview
    Table 152. Genea Fertility Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 153. Genea Fertility Non-invasive Preimplantation Genetic Testing Product
    Table 154. Genea Fertility Recent Developments/Updates
    Table 155. Bioarray Corporation Information
    Table 156. Bioarray Description and Business Overview
    Table 157. Bioarray Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 158. Bioarray Non-invasive Preimplantation Genetic Testing Product
    Table 159. Bioarray Recent Developments/Updates
    Table 160. GeneMind Biosciences Corporation Information
    Table 161. GeneMind Biosciences Description and Business Overview
    Table 162. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 163. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product
    Table 164. GeneMind Biosciences Recent Developments/Updates
    Table 165. Unimed Biotech Corporation Information
    Table 166. Unimed Biotech Description and Business Overview
    Table 167. Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 168. Unimed Biotech Non-invasive Preimplantation Genetic Testing Product
    Table 169. Unimed Biotech Recent Developments/Updates
    Table 170. Key Raw Materials Lists
    Table 171. Raw Materials Key Suppliers Lists
    Table 172. Non-invasive Preimplantation Genetic Testing Distributors List
    Table 173. Non-invasive Preimplantation Genetic Testing Customers List
    Table 174. Non-invasive Preimplantation Genetic Testing Market Trends
    Table 175. Non-invasive Preimplantation Genetic Testing Market Drivers
    Table 176. Non-invasive Preimplantation Genetic Testing Market Challenges
    Table 177. Non-invasive Preimplantation Genetic Testing Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Non-invasive Preimplantation Genetic Testing
    Figure 2. Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Non-invasive Preimplantation Genetic Testing Market Share by Type in 2022 & 2029
    Figure 4. Preimplantation Genetic Screening Product Picture
    Figure 5. Preimplantation Genetic Diagnosis Product Picture
    Figure 6. Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Non-invasive Preimplantation Genetic Testing Market Share by Application in 2022 & 2029
    Figure 8. Hospitals
    Figure 9. Diagnostic Laboratories
    Figure 10. Other
    Figure 11. Global Non-invasive Preimplantation Genetic Testing Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Non-invasive Preimplantation Genetic Testing Market Size (2018-2029) & (US$ Million)
    Figure 13. Global Non-invasive Preimplantation Genetic Testing Sales (2018-2029) & (K Units)
    Figure 14. Global Non-invasive Preimplantation Genetic Testing Average Price (US$/Unit) & (2018-2029)
    Figure 15. Non-invasive Preimplantation Genetic Testing Report Years Considered
    Figure 16. Non-invasive Preimplantation Genetic Testing Sales Share by Manufacturers in 2022
    Figure 17. Global Non-invasive Preimplantation Genetic Testing Revenue Share by Manufacturers in 2022
    Figure 18. The Global 5 and 10 Largest Non-invasive Preimplantation Genetic Testing Players: Market Share by Revenue in 2022
    Figure 19. Non-invasive Preimplantation Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 20. Global Non-invasive Preimplantation Genetic Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 21. North America Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2018-2029)
    Figure 22. North America Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2018-2029)
    Figure 23. United States Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 24. Canada Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2018-2029)
    Figure 26. Europe Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2018-2029)
    Figure 27. Germany Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. France Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. U.K. Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Italy Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Russia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Asia Pacific Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2018-2029)
    Figure 33. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2018-2029)
    Figure 34. China Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Japan Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. South Korea Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. India Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Australia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. China Taiwan Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Southeast Asia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Latin America Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2018-2029)
    Figure 42. Latin America Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2018-2029)
    Figure 43. Mexico Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Brazil Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Argentina Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Colombia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2018-2029)
    Figure 48. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2018-2029)
    Figure 49. Turkey Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Saudi Arabia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. UAE Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Global Sales Market Share of Non-invasive Preimplantation Genetic Testing by Type (2018-2029)
    Figure 53. Global Revenue Market Share of Non-invasive Preimplantation Genetic Testing by Type (2018-2029)
    Figure 54. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Type (2018-2029)
    Figure 55. Global Sales Market Share of Non-invasive Preimplantation Genetic Testing by Application (2018-2029)
    Figure 56. Global Revenue Market Share of Non-invasive Preimplantation Genetic Testing by Application (2018-2029)
    Figure 57. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Application (2018-2029)
    Figure 58. Non-invasive Preimplantation Genetic Testing Value Chain
    Figure 59. Non-invasive Preimplantation Genetic Testing Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS